Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
出版年份 2021 全文链接
标题
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-11-18
DOI
10.3389/fonc.2021.763790
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy
- (2021) Shengnan Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
- (2021) Mahrukh M Syeda et al. LANCET ONCOLOGY
- Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy
- (2021) Kezhong Chen et al. Molecular Cancer
- Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients
- (2021) Aparna R. Parikh et al. CLINICAL CANCER RESEARCH
- Tracking Cancer Evolution through the Disease Course
- (2021) Chris Bailey et al. Cancer Discovery
- Liquid Biopsy: From Discovery to Clinical Application
- (2021) Catherine Alix-Panabières et al. Cancer Discovery
- Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
- (2021) Jeanne Tie et al. PLOS MEDICINE
- Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas
- (2021) Lawrence Hsu Lin et al. MODERN PATHOLOGY
- ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
- (2021) Thomas Powles et al. NATURE
- Concordance of DNA Repair Gene Mutations in Paired Primary Prostate Cancer Samples and Metastatic Tissue or Cell-Free DNA
- (2021) Michael T. Schweizer et al. JAMA Oncology
- cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
- (2021) Elodie Bohers et al. Pharmaceuticals
- Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC
- (2020) Matthew D. Hellmann et al. CLINICAL CANCER RESEARCH
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
- (2020) Alessandro Leal et al. Nature Communications
- Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
- (2020) Gabriella Cirmena et al. Journal of Oncology
- Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
- (2020) Caichen Li et al. Frontiers in Oncology
- Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
- (2020) Nicolas Guibert et al. European Respiratory Review
- Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer
- (2020) Heather A. Parsons et al. CLINICAL CANCER RESEARCH
- Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
- (2020) Hiu Ting Chan et al. Molecular Oncology
- Integrating genomic features for non-invasive early lung cancer detection
- (2020) Jacob J. Chabon et al. NATURE
- Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
- (2020) Jian Yang et al. Cell Death & Disease
- Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer
- (2020) Eric X. Chen et al. JAMA Oncology
- Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers
- (2020) Helena A. Yu et al. JAMA Oncology
- Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
- (2020) Pier Vitale Nuzzo et al. NATURE MEDICINE
- Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
- (2020) Farshad Nassiri et al. NATURE MEDICINE
- Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer
- (2020) Milan Radovich et al. JAMA Oncology
- Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
- (2020) Barzin Y. Nabet et al. CELL
- Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
- (2020) Nicholas C Turner et al. LANCET ONCOLOGY
- Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
- (2020) Yoshiaki Nakamura et al. NATURE MEDICINE
- Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
- (2020) Qu Zhang et al. Cancer Discovery
- Triplet therapy with palbociclib, taselisib and fulvestrant in PIK3CA mutant breast cancer and doublet palbociclib and taselisib in pathway mutant solid cancers.
- (2020) Javier Pascual et al. Cancer Discovery
- Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
- (2020) Muyun Peng et al. Frontiers in Oncology
- Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
- (2020) M.J.M. Magbanua et al. ANNALS OF ONCOLOGY
- Technical considerations for circulating tumor DNA detection in oncology
- (2019) Claire Franczak et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
- (2019) Zhijie Wang et al. JAMA Oncology
- Clinical utility of circulating tumor DNA for colorectal cancer
- (2019) Hiroki Osumi et al. CANCER SCIENCE
- Molecular residual disease and adjuvant trials design in solid tumors
- (2019) Maria Coakley et al. CLINICAL CANCER RESEARCH
- Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
- (2019) Emil Christensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
- (2019) Re-I Chin et al. Molecular Diagnosis & Therapy
- Genome-wide cell-free DNA fragmentation in patients with cancer
- (2019) Stephen Cristiano et al. NATURE
- Genetic Profiling of Non‐Small Cell Lung Cancer at Development of Resistance to First‐ or Second‐Generation EGFR‐TKIs by CAPP‐Seq Analysis of Circulating Tumor DNA
- (2019) Kohei Otsubo et al. ONCOLOGIST
- Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
- (2019) Yuxuan Wang et al. JAMA Oncology
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
- (2019) Zhixiong Cai et al. CLINICAL CANCER RESEARCH
- Tumor genomic profiling guides metastatic gastric cancer patients to targeted treatment: The VIKTORY Umbrella Trial
- (2019) Jeeyun Lee et al. Cancer Discovery
- Circulating Tumor DNA as a Marker for Disease Relapse in Early-Stage Breast Cancer—Bad Blood
- (2019) Swathi Karthikeyan et al. JAMA Oncology
- Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
- (2019) Isaac Garcia-Murillas et al. JAMA Oncology
- Perioperative dynamic changes in circulating tumor DNA in lung cancer patients (DYNAMIC)
- (2019) Kezhong Chen et al. CLINICAL CANCER RESEARCH
- Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis
- (2019) Ben O’Leary et al. CLINICAL CHEMISTRY
- DYNAMIC insights into MRD responses early after resection of NSCLC
- (2019) David Killock Nature Reviews Clinical Oncology
- Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
- (2019) Bradon R. McDonald et al. Science Translational Medicine
- Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice
- (2019) Robin Imperial et al. Cancers
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- Profiling of circulating free DNA using targeted and genome wide sequencing in patients with Small Cell Lung Cancer
- (2019) Sumitra Mohan et al. Journal of Thoracic Oncology
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine
- (2019) Mohammad Amin Kerachian et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
- (2018) Daniel G. Stover et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
- (2018) Davina Gale et al. PLoS One
- Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
- (2018) Ben O’Leary et al. Nature Communications
- Plasma DNA and Metastatic Castration-Resistant Prostate Cancer: The Odyssey to a Clinical Biomarker Test
- (2018) Anuradha Jayaram et al. Cancer Discovery
- Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
- (2018) Zhijie Wang et al. Lancet Respiratory Medicine
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
- (2018) Luc Cabel et al. Nature Reviews Clinical Oncology
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- Circulating tumor DNA detection: A potential tool for colorectal cancer management (Review)
- (2018) Huizi Li et al. Oncology Letters
- BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
- (2018) Kevin K Lin et al. Cancer Discovery
- Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
- (2018) Chiara Cremolini et al. JAMA Oncology
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
- (2017) Mathilde Postel et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- Prostate cancer: Mutations in ctDNA reflect features of metastatic disease
- (2017) Peter Sidaway Nature Reviews Clinical Oncology
- Targeted therapy: ctDNA identified in patients with CUP
- (2017) Peter Sidaway Nature Reviews Clinical Oncology
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer
- (2017) Iñaki Comino-Mendez et al. Cancer Discovery
- Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
- (2017) Aadel A. Chaudhuri et al. Cancer Discovery
- Multiplex KRAS G12/G13 Mutation Testing of Unamplified Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using Droplet Digital Polymerase Chain Reaction
- (2016) F. Janku et al. ANNALS OF ONCOLOGY
- Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer
- (2016) Heather A. Parsons et al. CLINICAL CANCER RESEARCH
- Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer
- (2016) Katsutoshi Shoda et al. Gastric Cancer
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease
- (2016) Rafael Rosell et al. Nature Reviews Clinical Oncology
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2016) Alexander W. Wyatt et al. JAMA Oncology
- Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
- (2015) J. Belic et al. CLINICAL CHEMISTRY
- Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq
- (2015) Scott V Bratman et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- Methylome analysis using MeDIP-seq with low DNA concentrations
- (2012) Oluwatosin Taiwo et al. Nature Protocols
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More